T. Rowe Price Associates’s Spyre Therapeutics SYRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13.9M | Buy |
930,481
+681,939
| +274% | +$10.2M | ﹤0.01% | 1050 |
|
|
2025
Q1 | $4.01M | Sell |
248,542
-257,908
| -51% | -$4.16M | ﹤0.01% | 1315 |
|
|
2024
Q4 | $11.8M | Buy |
506,450
+77,323
| +18% | +$1.8M | ﹤0.01% | 1116 |
|
|
2024
Q3 | $12.6M | Buy |
429,127
+121,151
| +39% | +$3.56M | ﹤0.01% | 1099 |
|
|
2024
Q2 | $7.24M | Buy |
307,976
+229,447
| +292% | +$5.4M | ﹤0.01% | 1154 |
|
|
2024
Q1 | $2.98M | Buy |
+78,529
| New | +$2.98M | ﹤0.01% | 1388 |
|